Related Experiment Video
Updated: May 10, 2026

A General Method for Evaluating Deep Brain Stimulation Effects on Intravenous Methamphetamine Self-Administration
Published on: January 22, 2016
[Antibiotic drug minocycline: a potential therapeutic drug for methamphetamine-related disorders]
Kenji Hashimoto1, Tamaki Ishima, Yuko Fujita
1Division of Clinical Neuroscience, Chiba University Center for Forensic Mental Health, 1-8-1 Inohana, Chuo-ku, Chiba 260-8670, Japan. hashimoto@faculty.chiba-u.jp
Abstract:
Accumulating evidence suggests a role of inflammation in the pathophysiology of a number of neuropsychiatric diseases. The second generation antibiotic drug minocycline has potent neuroprotective and anti-inflammatory effects. We reported that minocycline could attenuate behavioral abnormalities and dopaminergic neurotoxicity in mice after administration of methamphetamine or 3,4-methylenedioxymethamphetamine (MDMA). Furthermore, we reported that minocycline was effective in the animal models of schizophrenia. Moreover, a double-blind, placebo-control, cross-over study showed that minocycline was effective in the rewarding effects in healthy human subjects. In this article, we would like to discuss minocycline as a potential therapeutic drug for methamphetamine-related disorders.
Related Concept Videos
Clinical Significance of Antibiotic Resistance
Therapeutic Drug Monitoring: Affecting Factors
Inhibitors of Bacterial Protein Synthesis
Antidepressant Drugs: MAOIs and Other Agents
Drug Therapy
Antianxiety Medications
Combined Effects of Drugs: Synergism
Such synergistic combinations...

